首页> 外文期刊>Neuro-Oncology >Non-invasive in vivo assessment of IDH1 mutational status in glioma
【24h】

Non-invasive in vivo assessment of IDH1 mutational status in glioma

机译:神经胶质瘤中IDH1突变状态的非侵入性体内评估

获取原文
获取原文并翻译 | 示例
           

摘要

Recent advances in the ability to generate and solubilize ~(13)C hyper-polarized compounds followed by injection and analysis with ~(13)C MR spectroscopy have given investigators the ability to non-invasively follow the fate of specific metabolites in vivo. Hyperpo-larized probes can be used to monitor conversion of pyruvate to lactate, to measure pH, and to assess redox potential among other uses. 2-Hydroxyglutarate (2-HG) production is a target for anti-glioma therapy in tumors with mutant isocitrate dehydro-genase 1 (IDH1). Chaumeil and colleagues performed ~(13)C MR spectroscopy to follow the fate of hyperpolarized [1-~(13)C] alpha-ketoglutarate (α-KG) in mutant and wildtype IDH1 tumors.
机译:产生和溶解〜(13)C超极化化合物,随后通过〜(13)C MR光谱进行注射和分析的能力的最新进展使研究人员能够无创地跟踪体内特定代谢产物的命运。超极化探针可用于监控丙酮酸向乳酸的转化,测量pH值以及评估氧化还原电势。 2-羟基戊二酸(2-HG)的生产是具有突变型异柠檬酸脱氢酶1(IDH1)的肿瘤抗神经胶质瘤治疗的目标。 Chaumeil及其同事进行了〜(13)C MR光谱分析,以追踪突变和野生型IDH1肿瘤中超极化[1-〜(13)C]α-酮戊二酸(α-KG)的命运。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号